SESARAM boosts anti-hemorrhagic drug stock with investment over 700 thousand euros
The Regional Secretariat for Health and Civil Protection has published Ordinance no. 179/2026, which proceeds with the redistribution and amendment of budgetary burdens for the acquisition of anti-hemorrhagic drugs, specifically the medication Eftrenonacog Alfa, intended for the Health Service of the Autonomous Region of Madeira, EPERAM (SESARAM).
The global base price for the acquisition is 706,212.15 €, plus VAT at a rate of 6%. The financial burden has been fully allocated to the 2026 fiscal year, ensuring the continuity of specialized healthcare required for users of the regional service.
Related articles
Marco Antonio Negreira Magalhaes appointed Division Head at the Regional Health Directorate
Engineer Marco Antonio Negreira Magalhaes takes over as head of the Licensing and Environmental Health Division at the Regional Health Directorate.
SESARAM invests over 4.4 million euros in volume expanders
The Regional Government has authorized the distribution of budgetary charges for the acquisition of volume expanders for SESARAM, in a four-year contract.
Regional Government renews lease for Dr. Nélio Mendonça Hospital outpatient clinic
The Regional Government of Madeira has approved the redistribution of budget charges for the renewal of the lease for the space housing the Dr. Nélio Mendonça Hospital outpatient clinic.